{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:59:20Z","timestamp":1770983960966,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Il Farmaco"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.farmac.2005.01.006","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T11:24:43Z","timestamp":1113564283000},"page":"439-443","source":"Crossref","is-referenced-by-count":6,"title":["Structure\u2013Retention Relationship in a Series of Chiral 1,4-Disubstituted Piperazine Derivatives on Carbohydrate Chiral Stationary Phases"],"prefix":"10.1016","volume":"60","author":[{"given":"Zdzis\u0142aw","family":"Chilmonczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0141ukasz","family":"Sienicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo\u017cena","family":"\u0141ozowicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Lisowska-Ku\u017amicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Jo\u0144czyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan Y.","family":"Aboul-Enein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.farmac.2005.01.006_bib1","series-title":"Chiral Molecules","author":"Simonyi","year":"1989"},{"key":"10.1016\/j.farmac.2005.01.006_bib2","series-title":"\u201cThe Impact of Chirality on Drug Development and Use\u201d","author":"Aboul-Enein","year":"1997"},{"key":"10.1016\/j.farmac.2005.01.006_bib3","series-title":"Applications to Pharmaceutical Compounds","article-title":"Chiral Separations by HPLC","author":"Krstulovi\u0107","year":"1989"},{"key":"10.1016\/j.farmac.2005.01.006_bib4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1021\/cr00092a006","article-title":"Consideration of chiral recognition relevant to the liquid chromatography separation of enantiomers","volume":"89","author":"Pirkle","year":"1989","journal-title":"Chem. Rev."},{"key":"10.1016\/j.farmac.2005.01.006_bib5","first-page":"279","article-title":"Chromatographic resolution of enantiomers. I. Methods","volume":"47","author":"Bojarski","year":"1993","journal-title":"Wiad. Chem."},{"key":"10.1016\/j.farmac.2005.01.006_bib6","first-page":"419","article-title":"Chromatographic resolution of enantiomers. II. Mechanisms and applications. I. Methods","volume":"47","author":"Bojarski","year":"1993","journal-title":"Wiad. Chem."},{"key":"10.1016\/j.farmac.2005.01.006_bib7","series-title":"Chiral Separations by Liquid Chromatography and Related Technologies\u201d","first-page":"21","article-title":"Polysaccharide-based chiral stationary phases \u201cChapter 2","author":"Aboul-Enein","year":"2003"},{"key":"10.1016\/j.farmac.2005.01.006_bib8","series-title":"The impact of stereochemistry on drug development and use. Chemical Analysis Series","first-page":"403","article-title":"Chiral recognition mechanisms of polysaccharide stationary phases","author":"Yashima","year":"1997"},{"key":"10.1016\/j.farmac.2005.01.006_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0021-9673(97)00714-0","article-title":"Non-linear structure-enantioselective retention relationships in a homologous series of 1,4-disubstituted piperazine derivatives","volume":"788","author":"Chilmonczyk","year":"1997","journal-title":"J. Chromatogr. A."},{"key":"10.1016\/j.farmac.2005.01.006_bib10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/(SICI)1520-636X(1999)11:10<790::AID-CHIR9>3.0.CO;2-1","article-title":"Enantiomeric separation of 1,4-disubstituted piperazine derivatives on two cellulose chiralcel OD and OJ and one amylose chiralpak AD chiral selectors","volume":"11","author":"Chilmonczyk","year":"1999","journal-title":"Chirality"},{"key":"10.1016\/j.farmac.2005.01.006_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0378-4347(98)00429-0","article-title":"Application of chiral chromatographic parameters in quantitative structure\u2013activity relationship analysis of homologous malatione derivatives","volume":"729","author":"Chilmonczyk","year":"1998","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.farmac.2005.01.006_bib12","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/1520-636X(2001)13:3<148::AID-CHIR1012>3.0.CO;2-Y","article-title":"Enantioselectivity of 3-amino-2-oxazolidinone derivatives with potential psychotropic activity on cellulose tris(4-methylbenzoate) chiral selector","volume":"13","author":"Chilmoncyyk","year":"2001","journal-title":"Chirality"},{"key":"10.1016\/j.farmac.2005.01.006_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ardp.19953280218","article-title":"Some analogues of 1-4-disubstituted piperazines as hypnotic and sedative agents","volume":"328","author":"Chilmonczyk","year":"1995","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.farmac.2005.01.006_bib14","first-page":"431","article-title":"Structure\u2013activity relationship in a series of new 1,4-disubstituted piperazine derivatives with hypnotic activity","volume":"48","author":"Chilmonczyk","year":"1996","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.farmac.2005.01.006_bib15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1211\/0022357021778844","article-title":"Pharmacological properties and SAR of new 1,4-disubstituted piperazine derivatives with hypnotic-sedative activity","volume":"54","author":"Chilmonczyk","year":"2002","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.farmac.2005.01.006_bib16","first-page":"71","article-title":"Novel buspirone-like 5-HT1A","volume":"75","author":"Krajewski","year":"2001","journal-title":"Receptor Ligands. Pol. J. Chem."}],"container-title":["Il Farmaco"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014827X05000285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014827X05000285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T09:26:26Z","timestamp":1548581186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014827X05000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0014827X05000285"],"URL":"https:\/\/doi.org\/10.1016\/j.farmac.2005.01.006","relation":{},"ISSN":["0014-827X"],"issn-type":[{"value":"0014-827X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}